Gano Kyle
Reporting owner on Forms 3, 4 and 5, CIK 1567160.
Gano Kyle reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-03.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| NBIX · NEUROCRINE BIOSCIENCES INCCIK 914475 | director, officer (Chief Executive Officer) | 1 | 2026-11-03 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| NBIX · NEUROCRINE BIOSCIENCES INCCommon Stock | 2026-11-01 | M exercised | +614 | $0 | 155,342 | Form 4 |
| NBIX · NEUROCRINE BIOSCIENCES INCCommon Stock | 2026-11-01 | F withheld for tax | -332 | $146.1 | 155,010 | Form 4 |
| NBIX · NEUROCRINE BIOSCIENCES INCRestricted Stock Unit, derivative | 2026-11-01 | M exercised | -614 | $0 | 1,228 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001567160-26-000011 | NEUROCRINE BIOSCIENCES INC | 2026-11-03 |